Anteris Technologies Global Corp. (AVR)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$9.04+3.67%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · AVR
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | |
|---|---|---|---|---|
| Revenues | ||||
| Revenues | 2.2 | 1.9 | 2.7 | — |
| Cost of Revenues | 0.6 | 0.6 | 1.4 | — |
| Operating Expenses & Income | ||||
| Selling, General & Admin | 30.8 | 26.1 | 28.2 | — |
| R&D Expenses | 77.2 | 69.1 | 51.5 | — |
| Operating Income | (106.2) | (93.9) | (78.4) | — |
| Earnings from Continuing Operations | ||||
| EBT, Incl. Unusual Items | (102.4) | (94.2) | (76.0) | — |
| Income Tax Expense | — | — | 0.0 | — |
| Net Income | ||||
| Minority Interest | 0.7 | (0.1) | 0.3 | — |
| Net Income | (103.6) | (94.1) | (76.3) | — |
| Per Share | ||||
| Basic EPS | (1.06) | (2.55) | (3.68) | — |
| Diluted EPS | (1.06) | (2.55) | (3.68) | — |
| Revenue per Share | 0.02 | — | — | — |
| Basic Weighted Avg Shares | 97.3 | 36.9 | 20.3 | — |
| Diluted Weighted Avg Shares | 97.3 | 36.9 | 20.3 | — |
| Supplemental | ||||
| EBITDA | — | (92.2) | (76.9) | — |
| EBIT | (106.2) | (93.9) | (78.4) | — |
| Effective Tax Rate | — | — | 0.0% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.